EP 80317 a prototype of a new class of anti-atherosclerotic agents

被引:0
|
作者
Ong, H.
Harb, D.
Bujold, K.
Febbraio, M.
Tremblay, A. .
Sirois, M. G.
Marleau, S.
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada
[3] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada
[4] Montreal Heart Inst, Montreal, PQ, Canada
关键词
CD36; atherosclerosis; growth hormone - releasing peptides; LXR alpha;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:256 / 256
页数:1
相关论文
共 50 条
  • [1] New trends in anti-atherosclerotic agents
    Napoli, C
    Sica, V
    Pignalosa, O
    de Nigris, F
    [J]. CURRENT MEDICINAL CHEMISTRY, 2005, 12 (15) : 1755 - 1772
  • [2] The anti-atherosclerotic effects of EP 80317, a selective ligand of CD36, are associated with anti-inflammatory actions
    Harb, D.
    Ong, H.
    Marleau, S.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 184C - 184C
  • [3] THE ANTI-ATHEROSCLEROTIC EFFECT OF EP80317, A SELECTIVE LIGAND OF CD36, IS ASSOCIATED WITH ANTI-INFLAMMATORY ACTIONS
    Ong, H.
    Harb, D.
    Febbraio, M.
    Marleau, S.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 166 - 166
  • [4] Lactobacilli and Bifidobacterium as anti-atherosclerotic agents
    Abdi, Milad
    Ghaleh, Hadi Esmaeili Gouvarchin
    Ranjbar, Reza
    [J]. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 25 (08) : 934 - 946
  • [5] Growth Hormone-Releasing Peptides: a novel class of anti-atherosclerotic agents
    Harb, Diala
    Bujold, Kim
    Febbraio, Maria
    Sirois, Martin G.
    Tremblay, Andre
    Ong, Huy
    Marleau, Sylvie
    [J]. INFLAMMATION RESEARCH, 2005, 54 : S207 - S207
  • [6] NEW STRATEGIES IN THE DEVELOPMENT OF ANTI-ATHEROSCLEROTIC DRUGS
    SIRTORI, CR
    TREMOLI, E
    PAOLETTI, R
    [J]. ARTERY, 1980, 8 (06) : 507 - 518
  • [7] In search of antioxidants and anti-atherosclerotic agents from herbal medicines
    Shiao, Ming-Shi
    Chiu, Jing-Jing
    Chang, Bao-Wen
    Wang, Jane
    Jen, Wei-Ping
    Wu, Ye-Jer
    Chen, Yuh-Lien
    [J]. BIOFACTORS, 2008, 34 (02) : 147 - 157
  • [8] Analysis of anti-apoptotic intracellular viral serpins as anti-atherosclerotic agents
    Liu, LY
    Viswanathan, K
    Dai, EB
    Turner, PC
    Togonu-Bickersteth, J
    Pang, B
    Li, Y
    Moyer, RW
    McFadden, G
    Lucas, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 54A - 54A
  • [9] EP2300 COMPOUNDS: FOCUSING ON THE ANTI-ATHEROSCLEROTIC PROPERTIES OF SQUALENE SYNTHASE INHIBITORS
    Tavridou, A.
    Manolopoulos, V. G.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 54 - 54
  • [10] Emerging Anti-Atherosclerotic Therapies
    Gluba-Brzozka, Anna
    Franczyk, Beata
    Rysz-Gorzynska, Magdalena
    Lawinski, Janusz
    Rysz, Jacek
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)